Sciety
Venture capitalStockholm · Seed–Growth · 21 people tracked
Investment thesis
Sciety focuses on life science and digital health companies across the Nordic region, particularly Sweden, which it views as Northern Europe's most dynamic life sciences market. It targets companies with potential to become market leaders, drawing on deep industry expertise and a rigorous, data-driven selection process. Sciety Venture Partners connects experienced investors — private investment firms, family offices and specialised investment companies — and taps an extensive network of Nordic and European VC and corporate VC firms to co-invest. The firm leads the investment process, typically completing first capital injection within a few months, and stays actively engaged long-term, supporting companies with customer and partner introductions and board expertise ahead of future rounds, M&A or IPO.
Source: firm website, verified Aug 3, 2026.
Team · 21 people
from the firm's websiteWhat they invest in
from 7 of 13 portfolio companiesBiotech ×5Medical Devices ×3AI & Machine Learning ×2Healthtech ×2Deep Tech ×1Digital Health ×1EdTech ×1Impact & Social Good ×1
HQs:Sweden×3United States×1
Investments · 13 tracked
founders shown can be your intro pathDeveloped a new type of targeted radioimmunotherapy with first-in-class potential showing 100% survival rate in animal studies.
Elypta develops a metabolism-based liquid biopsy that measures the GAGome, a set of biomarkers of tumor metabolism, and applies machine learning to noninvasively detect cancer signatures.
AI & Machine LearningBiotechMedical Devices
Co-investorsBonnier CapitalChalmers Ventures ABIndustrifondenNavigare VenturesNina CapitalNorrsken VC
Provides proprietary software solutions that help hospitals implement best practice throughout the entire care chain from diagnosis to rehabilitation.
Karolinska Institutet is a Swedish medical university offering medical education programs and conducting a large share of Sweden's academic medical research.
EdTech
Develops an innovative bone substitute for spinal surgery to improve bone healing in spinal fusion procedures.
Provides groundbreaking technology and instruments for large-scale production of precision drugs including peptides and oligonucleotides.
Clinical-stage pharmaceutical company developing a first-in-class treatment for neuropathic pain with blockbuster potential in adjacent indications.
SAGA Diagnostics develops Pathlight, a blood-based, tumor-informed multi-cancer test for detecting molecular residual disease (MRD) using whole-genome sequencing and personalized multiplex digital PCR assays to track circulating tumor DNA.
AI & Machine LearningBiotechDigital Health
Co-investorsFSGHadean VenturesLU Innovation
SciLifeLab is a Swedish national research infrastructure providing access to molecular bioscience technologies—including genomics, proteomics, spatial omics, imaging, structural biology, drug discovery, and bioinformatics—for users from academia, industry, and healthcare.
BiotechDeep TechHealthtech
Summa Equity is a thematic private equity investment firm that invests in and develops mid-market companies addressing global challenges.
Impact & Social Good
Co-investorsBlue Haven Initiative
Portfolio news
latest coverage across their companiesKarolinska Institutet · n24.com.tr · Aug 22, 2026
SAGA Diagnostics · arcticstartup.com · Aug 20, 2026
Summa Equity · summaequity.com · Jan 20, 2026
Frequently asked questions
- How many investments has Sciety made?
- Sciety has 11 tracked investments.
- What stage does Sciety invest at?
- Sciety invests at the Seed, Series A, Series B, Series C, Growth stages.
- What sectors does Sciety focus on?
- Sciety focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is Sciety located?
- Sciety is headquartered in Stockholm, SE.
- Does Sciety lead rounds?
- Yes, Sciety leads investment rounds.
Images
Similar investors
Pontifax is an investment firm focused on life sciences and healthcare technologies, backing companies across all development stages from early research to clinical-stage growth.
Hadean Ventures is a European venture capital fund manager with a track record in life sciences, investing across sectors and stages in science-driven innovation addressing real-world challenges.
Alta Partners is a venture capital firm focused on the healthcare and life sciences sector, backing entrepreneurs building companies across biotechnology, therapeutics, and healthcare innovation.
EQT Life Sciences, formerly LSP, is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech globally. It is part of EQT Group.
Ally Bridge Group is a global healthcare investment manager focused on high-impact life sciences innovation across private and public markets.


























